SSII

SS Innovations International Inc. Common Stock
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$786.52M
P/E Ratio
EPS
$-0.05
Beta
0.56
52W High
$10.00
52W Low
$3.11
50-Day MA
$3.70
200-Day MA
$5.08
Dividend Yield
Profit Margin
-20.70%
Forward P/E
PEG Ratio

About SS Innovations International Inc. Common Stock

SS Innovations International, Inc., is a commercial-stage surgical robotics company in India and internationally. The company is headquartered in Gurugram, India.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$48.47M
Gross Profit (TTM)$23.78M
EBITDA$-4.72M
Operating Margin-32.80%
Return on Equity-21.10%
Return on Assets-4.80%
Revenue/Share (TTM)$0.25
Book Value$0.27
Price-to-Book14.54
Price-to-Sales (TTM)16.23
EV/Revenue16.31
EV/EBITDA-24.73
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)116.80%
Shares Outstanding$200.13M
Float$40.32M
% Insiders80.21%
% Institutions0.87%

Historical Volatility

HV 10-Day
80.04%
HV 20-Day
88.72%
HV 30-Day
83.30%
HV 60-Day
72.43%
HV Rank
40.5%

Volatility is currently contracting

Latest News

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event

GlobeNewsWire7/17/2026Neutral
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth

GlobeNewsWire7/14/2026Neutral
IBN Initiates Coverage of SS Innovations International, Inc.

AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via  IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN , a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

GlobeNewsWire7/7/2026Neutral
SS Innovations' Surgical Robotics Expansion Continues As Revenue More Than Doubles

SS Innovations (SSII) posted another quarter where revenue more than doubled compared to the prior year. Consistent sequential revenue acceleration highlights strong operational momentum following similar Q4 FY25 performance. Potential US and European regulatory approval provide significant asymmetric reward.

Seeking Alpha6/19/2026Positive
SS Innovations Announces Completion of World's Longest-Distance Robotic Telesurgery

FORT LAUDERDALE, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a robot-assisted heart procedure was successfully performed with the SSi Mantra surgical robotic system (the “SSi Mantra”) across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India, making it the world's longest-distance robotic telesurgery ever conducted.

GlobeNewsWire6/4/2026Neutral
UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors

Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therapeutics, cancer care, longevity medicine, and pharmacogenetics – particularly within the rapidly growing direct-pay healthcare sector.

Newsfile Corp5/19/2026Neutral
SS Innovations Reports First Quarter 2026 Financial Results

FORT LAUDERDALE, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended March 31, 2026.

GlobeNewsWire5/13/2026Neutral
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress

Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.

MCAP MediaWire5/11/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SSII and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026